Medical Cannabis and Anxiety: What the Evidence Actually Shows
Explore what the evidence truly says about medical cannabis for anxiety—how THC, CBD, dose, and individual response shape outcomes and safety.
Articles
Cannabis and Ménière’s Disease: What the Evidence Actually Shows
Cannabis and Ménière’s disease: what science says about CBD, THC, vertigo, and tinnitus—evidence is inconclusive and not a proven cure.
Cannabinoids and Stroke: Promising Preclinical Findings
Promising preclinical findings on cannabinoids and stroke, but human evidence is limited; discover why lab results haven't yet translated into stroke care.
CBD Is Hemp-Derived, but FDA Rules Still Govern How It Can Be Sold
CBD is hemp-derived yet tightly regulated by the FDA - discover how Epidiolex, foods, and marketing claims shape what's allowed nationwide.
Centrifugal Partition Chromatography: A Flexible Alternative to Solid-Phase Purification
Explore CPC: a flexible, solvent-based alternative to solid-phase purification, delivering scalable, recoverable liquid-liquid separations for diverse samples.
Cannabis Has No Proven Role in Treating Meningitis, Though CBG Shows Early Antibacterial Potential
Discover the evolving science on cannabis, CBG and meningitis, with early antibacterial signals and the limits of current evidence.
Cannabis May Ease Neuropathic Pain After Spinal Cord Injury
Could medical cannabis ease neuropathic pain after spinal cord injury? Learn what the latest evidence says, risks, and when it may help as an adjunct.
DNA-Based Testing Offers a Clearer View of Microbial Contamination in Cannabis
DNA-based testing offers a clearer view of cannabis microbial safety, showing how qPCR and sequencing enhance detection beyond culture methods.
Cannabinoids May Ease Multiple Sclerosis-Related Spasticity
Could cannabis-based medicines ease MS-related spasticity? Explore the latest evidence, safety considerations, and when to talk to a clinician.
Medical Cannabis Laws Were Linked to Lower Opioid Dispensing Among Some Cancer Patients
A JAMA Oncology study links state medical marijuana laws to lower opioid dispensing in some cancer patients, but causation isn't proven.